Five years after being diagnosed with colon cancer, I would like to share how my support system continues to play a role in my life after active treatment.

Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among ...

Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; ...

Walking the woods shows me how to release fear, grief, and expectations, trusting that letting go nourishes growth, ...

For men with prostate cancer, radical prostatectomy, or surgical removal of the prostate, isn’t guaranteed to be curative, as ...

The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers.

Dr. Joshua Sabari spoke with advocate Chris Conneran on his journey from caregiver to champion for KRAS-mutant cancer patients and families.